No. CS/SB 844
Filed under Healthcare.
Sickle Cell Disease Care Management and Treatment Continuing Education; Revising requirements for a continuing education course on prescribing controlled substances which health care practitioners are required to complete, etc.
Plain English Summary
AI-GENERATEDFlorida's mandatory course on prescribing controlled substances, required every two years for license renewal, must now also cover treating pain in patients with sickle cell disease, alongside its existing opioid-related topics.
The course still covers prescribing standards, alternatives, nonpharmacological therapies, emergency opioid antagonists, and addiction risk across all stages of acute pain treatment -- sickle cell pain management is added on top, not swapped in for anything else.
AIAdds a sixth required topic to the mandatory controlled-substances prescribing course: the treatment of pain in patients with sickle cell disease, alongside the course's five existing required topics.